The present invention relates to a composition comprising an extract or a
concentrate of Butyrospermum parkii as a dietary supplement or a
pharmaceutical composition and to the use of such compositions for the
preparation of a medicament or a dietary supplement for the suppression
of hypersensitivity and/or inflammatory reaction. The composition may
optionally be formulated with a pharmaceutically acceptable carrier for
systemic or topical administration. More specifically, the invention
relates to a dietary supplement or a pharmaceutical composition
comprising an extract or a concentrate of Butyrospermum parkii, wherein
said extract or concentrate contains Butyrospermum-triterpenes and
optionally the sterols stigmasterol, avanasterol,
24-methyl-cholest-7-enol, karitesterol A, karitesterol B and
.alpha.-spinasterol.